The Human Plutonium
Injection Experiments
214
Los Alamos Science Number 23 1995
Did the patients who were injected with
plutonium in 1945 and 1946 give any
form of consent? This is a question that
probably cannot be answered unequivo-
cally. None of the people directly in-
volved in the experiments are living now,
and documents that would shed light one
way or another on this question are scat-
tered and incomplete. Here, we review
some of the evidence that has come to
light coupled with a few speculative
thoughts.
One fact is almost certain—the patients
were not told that they were being inject-
ed with plutonium. Up until the end of
the war, the word plutonium was a se-
cret. Even in the classified documents of
the time, plutonium was referred to with
the code words “49” and “product.”
Were the patients told they were being
injected with a radioactive substance?
Possibly not. Although research with ra-
dioactive tracers was publicized before
the war, reference to radioactive materi-
als in the context of the Manhattan Pro-
ject may have been considered a security
risk as well. But we do not know this for
sure.
Is informed consent still possible if the
patients are
not told that the material
under study is radioactive plutonium?
Many experts feel the answer is yes, be-
cause these two words, especially in the
forties, would not have done anything to
help the patient assess the risk. More-
over, it would be possible to give the pa-
tient a practical understanding of the risk
and benefits of the study without men-
tioning radioactivity or plutonium. The
medical personnel in charge would em-
phasize that the patient would be in-
volved in a research study important to
the war effort, their participation was vol-
untary, and there was some personal
risk, which the researchers, to the best of
their knowledge, felt was small. The na-
ture of the experiment could have been
described as follows:
Each of you will be injected with a
material that will circulate through
your body and then be slowly excret-
ed. Blood and other clinical tests will
be done and all your excreta will be
collected for a period of time. Most
of the material will remain in your
body, making it a long-term risk, but
at a level close to what is considered
safe for people now working with the
material. Previous experiments on
animals have given us an idea of the
acute toxicity of the material, and
what you receive will be hundreds of
times lower. The purpose of the
study is to learn the fraction of mate-
rial excreted as a function of time so
we can tell when a worker is getting
too much in his body.
Would the investigators have told the pa-
tients something along these lines?
Quite possibly. Participants were re-
quired to collect their urine and feces for
a month or more, as well as to submit to
clinical examinations, blood tests, dietary
regulations, and so forth. Something
surely was said about the necessity for
these indignities, and what better way to
motivate them than to emphasize that the
study was important to the security of a
nation at war. Because of the collection
period required for the study, patients
that would benefit from a stay in a hospi-
tal ward were more suitable than normal
subjects, such as workers or wives.
The Polonium studies. Along these
lines, we have some evidence of what
was told to patients at the Rochester site
in 1944 when the earlier human injection
study on polonium was done. An article
in
Biological
Studies with Polonium, Radi-
um, and Plutonium, published in 1950
after the war, states:
The general problem was outlined to
a number of hospital patients with no
previous or probable future contact
with polonium. Of the group who
volunteered as subjects, four men
and one woman were selected for
the excretion studies . . .
Taking these statements at face value
establishes a precedent for the manner in
which patients at Rochester were treated.
There is no reason why the investigators
could not have continued the same prac-
tice with the plutonium injectees.
Whether they did or not is not clear.
A 1946 memo. We now turn to evi-
dence that supports the possibility that no
consent was given. About five months
after the last Rochester patient had been
injected, authority was being transferred
from the Manhattan Project to the new
Atomic Energy Commission, and re-
search programs involving human injec-
tions with radioactive tracers were being
scrutinized. T. S. Chapman, Chief, Oper-
ations Branch, Research Division, in a
December 30, 1946, memo to the Area
Engineer in Berkeley, California, refers to
a proposal for research at the University
of California Hospital in San Francisco
and states that “preparations were being
made for injection in humans by Drs.
[Robert] Stone and [Earl] Miller [Stone
came to San Francisco after the war].”
The second paragraph continues:
These doctors state that the injec-
tions would probably be made
without the knowledge of the pa-
tient and that the physicians as-
sumed full responsibility. Such in-
jections were not divergent from
the normal experimental method
in the hospital and the patient
signed no release. A release was
held to be invalid.
The memo also states that the Medical
Division of the District Office had referred
reports on the project “to Colonel Cooney
[the new Medical Director of the Manhat-
tan Project] for review and approval is
withheld pending his opinion.” In fact, six
days earlier, Colonel Nichols of the Man-
hattan Project, after discussions with
Consent in the Human Plutonium Injection Experiments